SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-001984
Filing Date
2024-01-08
Accepted
2024-01-08 06:03:32
Documents
16
Period of Report
2024-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm242343d1_8k.htm   iXBRL 8-K 41142
2 EXHIBIT 10.1 tm242343d1_ex10-1.htm EX-10.1 60809
3 EXHIBIT 99.1 tm242343d1_ex99-1.htm EX-99.1 16842
8 GRAPHIC tm242343d1_ex99-1img01.jpg GRAPHIC 10438
  Complete submission text file 0001104659-24-001984.txt   374646

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zura-20240103.xsd EX-101.SCH 3495
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zura-20240103_def.xml EX-101.DEF 26908
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20240103_lab.xml EX-101.LAB 36974
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20240103_pre.xml EX-101.PRE 25532
10 EXTRACTED XBRL INSTANCE DOCUMENT tm242343d1_8k_htm.xml XML 5078
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 24518173
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)